Jacqueline Kraveka to Treatment Outcome
This is a "connection" page, showing publications Jacqueline Kraveka has written about Treatment Outcome.
Connection Strength
0.047
-
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma. Int J Cancer. 2020 12 01; 147(11):3152-3159.
Score: 0.019
-
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma. PLoS One. 2015; 10(5):e0127246.
Score: 0.014
-
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma. Cancer Med. 2015 Jun; 4(6):871-86.
Score: 0.014